8Jeunemaltre X, Chatelier G, Kreft-Jals C, vt al. Efficacy and tolerance of spironolactone in essential hepertension [J]. Am J Cardiol, 1987,60 (10) :820-825.
9Chapnmn N, Dobson J, Wilson S, et aL Efleet of spironolactone on blood pressure in subjects with resistant hypertension [J]. Hyperten- sion ,2007,25:839-845.
3Liao EC, Kish JB, Hertl MC. Incidental discovery of bilateral breast cancer in a 24-year-old man presenting with gyneco- mastia[J]. Ann Plast Surg ,2007, 58(6):673-676.
4Simon BE, Hoffman S, Kahn S. Classification and surgical correction of gynecomastia [J]. Plast Reconstr Surg,1973, 51(1):48-52.
5Wiesman IM, Lehman JA, Parker MG, et al. Gynecomastia: an outcome analysis[J]. Ann Plast Surg,2004, 53(2):97-101.
6Daniels IR, Layer GT. How should gynaecomastia be managed? [J] ANZ J Surg,2003, 73(4):213-216.
7Braunstein GD. Gynecomastia [J]. N Engl J Med,1993, 328(7): 490-495.
8Ismail AA, Barth JH. Endocrinology of gynaecomastia [J]. Ann Clin Biochem,2001, 38(Pt 6):596-607.
9Gikas P, Mokbel K. Management of gynaecomastia: an update [J]. Int J Clin Pratt, 2007, 61(7):1209-1215.
10Cakan N, Kamat D. Gynecomastia: evaluation and treatment recommendations for primary care providers [J]. Clin Pediatr (Phila) ,2007, 46(6):487-490.
